NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 218 filers reported holding NEVRO CORP in Q3 2020. The put-call ratio across all filers is 1.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,277,000 | +520.4% | 48,873 | +483.1% | 0.08% | +627.3% |
| Q2 2022 | $367,000 | -72.1% | 8,382 | -54.0% | 0.01% | -78.0% |
| Q1 2022 | $1,317,000 | +168.8% | 18,209 | +201.3% | 0.05% | +163.2% |
| Q4 2021 | $490,000 | -77.8% | 6,044 | -68.2% | 0.02% | -76.5% |
| Q3 2021 | $2,209,000 | +44.8% | 18,980 | +106.1% | 0.08% | +131.4% |
| Q2 2021 | $1,526,000 | +355.5% | 9,207 | +283.6% | 0.04% | +250.0% |
| Q1 2021 | $335,000 | +9.5% | 2,400 | +9.1% | 0.01% | -75.0% |
| Q3 2020 | $306,000 | – | 2,200 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,446,333 | $82,441,000 | 4.44% |
| Asymmetry Capital Management, L.P. | 31,379 | $1,789,000 | 1.65% |
| TIRSCHWELL & LOEWY INC | 194,470 | $11,085,000 | 1.38% |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | 673,480 | $38,388,000 | 1.22% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 525,040 | $29,927,000 | 1.07% |
| Orbimed Advisors | 1,357,691 | $77,388,000 | 0.93% |
| Sio Capital Management, LLC | 45,091 | $2,570,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 60,000 | $3,420,000 | 0.72% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 159,800 | $9,109,000 | 0.62% |
| Endurant Capital Management LP | 24,171 | $1,378,000 | 0.61% |